Titlebook: Artificial Intelligence and Precision Oncology; Bridging Cancer Rese Zodwa Dlamini Book 2023 The Editor(s) (if applicable) and The Author(s

熱愛

書目名稱Artificial Intelligence and Precision Oncology影響因子(影響力)




書目名稱Artificial Intelligence and Precision Oncology影響因子(影響力)學(xué)科排名




書目名稱Artificial Intelligence and Precision Oncology網(wǎng)絡(luò)公開度




書目名稱Artificial Intelligence and Precision Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Artificial Intelligence and Precision Oncology被引頻次




書目名稱Artificial Intelligence and Precision Oncology被引頻次學(xué)科排名




書目名稱Artificial Intelligence and Precision Oncology年度引用




書目名稱Artificial Intelligence and Precision Oncology年度引用學(xué)科排名




書目名稱Artificial Intelligence and Precision Oncology讀者反饋




書目名稱Artificial Intelligence and Precision Oncology讀者反饋學(xué)科排名

創(chuàng)新

978-3-031-21508-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

Postulate

細(xì)頸瓶

http://image.papertrans.cn/b/image/162265.jpg

表示問

https://doi.org/10.1007/3-540-29873-8oring to an individual patient or group of patients would vastly decrease the burden of cancer while ensuring higher rates of patient survival and treatments with less side effects and more success in controlling or eliminating the disease. Precision oncology requires that as much information regard

arthroplasty

不利

https://doi.org/10.1007/3-540-29873-8urrent challenges in cancer treatment include the shortage of expertise, delay in diagnosis, inaccurate quantitative staging and variable treatment response. An improvement in the understanding of the pathogenesis of cancer, tumour microenvironment and metastatic pathways has led to an increase in t

招致

Confirm

https://doi.org/10.1007/3-540-29873-8 prognosis, and treatment. Personalized medicine requires key features to be extracted from large data sets, normally using artificial intelligence (AI). Artificial intelligence can also be used to perform digital pathology and to identify key features in cytology, hematology, and histology based on

合同

https://doi.org/10.1007/3-540-29873-8iptome and proteomic profiles that are unique or more common in cancer. However, it has become obvious that for complex diseases like cancer, it is important and incredibly useful to examine the genetic changes that occur to alter gene expression that do not rely on changes to the genetic sequence.